|Regulation of inflammatory responses by IL-17F|
XO Yang, SH Chang, H Park, R Nurieva, B Shah, L Acero, YH Wang, ...
The Journal of experimental medicine 205 (5), 1063-1075, 2008
|The immune landscape of cancer|
V Thorsson, DL Gibbs, SD Brown, D Wolf, DS Bortone, THO Yang, ...
Immunity 48 (4), 812-830. e14, 2018
|Comprehensive characterization of cancer driver genes and mutations|
MH Bailey, C Tokheim, E Porta-Pardo, S Sengupta, D Bertrand, ...
Cell 173 (2), 371-385. e18, 2018
|Oncogenic signaling pathways in the cancer genome atlas|
F Sanchez-Vega, M Mina, J Armenia, WK Chatila, A Luna, KC La, ...
Cell 173 (2), 321-337. e10, 2018
|Cell-of-origin patterns dominate the molecular classification of 10,000 tumors from 33 types of cancer|
KA Hoadley, C Yau, T Hinoue, DM Wolf, AJ Lazar, E Drill, R Shen, ...
Cell 173 (2), 291-304. e6, 2018
|An integrated TCGA pan-cancer clinical data resource to drive high-quality survival outcome analytics|
J Liu, T Lichtenberg, KA Hoadley, LM Poisson, AJ Lazar, AD Cherniack, ...
Cell 173 (2), 400-416. e11, 2018
|Analysis of immune signatures in longitudinal tumor samples yields insight into biomarkers of response and mechanisms of resistance to immune checkpoint blockade|
PL Chen, W Roh, A Reuben, ZA Cooper, CN Spencer, PA Prieto, JP Miller, ...
Cancer discovery 6 (8), 827-837, 2016
|High frequency of PIK3R1 and PIK3R2 mutations in endometrial cancer elucidates a novel mechanism for regulation of PTEN protein stability|
LWT Cheung, BT Hennessy, J Li, S Yu, AP Myers, B Djordjevic, Y Lu, ...
Cancer discovery 1 (2), 170-185, 2011
|Integrated analyses identify a master microRNA regulatory network for the mesenchymal subtype in serous ovarian cancer|
D Yang, Y Sun, L Hu, H Zheng, P Ji, CV Pecot, Y Zhao, S Reynolds, ...
Cancer cell 23 (2), 186-199, 2013
|Uterine papillary serous carcinoma (UPSC): a single institution review of 129 cases|
BM Slomovitz, TW Burke, PJ Eifel, LM Ramondetta, EG Silva, A Jhingran, ...
Gynecologic oncology 91 (3), 463-469, 2003
|Gynecologic cancer as a “sentinel cancer” for women with hereditary nonpolyposis colorectal cancer syndrome|
KH Lu, M Dinh, W Kohlmann, P Watson, J Green, S Syngal, ...
Obstetrics & Gynecology 105 (3), 569-574, 2005
|Patterns of genomic loss of heterozygosity predict homologous recombination repair defects in epithelial ovarian cancer|
V Abkevich, KM Timms, BT Hennessy, J Potter, MS Carey, LA Meyer, ...
British journal of cancer 107 (10), 1776-1782, 2012
|Patterns of gene expression in different histotypes of epithelial ovarian cancer correlate with those in normal fallopian tube, endometrium, and colon|
RT Marquez, KA Baggerly, AP Patterson, J Liu, R Broaddus, M Frumovitz, ...
Clinical cancer research 11 (17), 6116-6126, 2005
|Feasibility of large-scale genomic testing to facilitate enrollment onto genomically matched clinical trials|
F Meric-Bernstam, L Brusco, K Shaw, C Horombe, S Kopetz, MA Davies, ...
Journal of clinical oncology 33 (25), 2753, 2015
|MicroRNA-196a targets annexin A1: a microRNA-mediated mechanism of annexin A1 downregulation in cancers|
R Luthra, RR Singh, MG Luthra, YX Li, C Hannah, AM Romans, ...
Oncogene 27 (52), 6667-6678, 2008
|Pathologic features of endometrial carcinoma associated with HNPCC: a comparison with sporadic endometrial carcinoma|
RR Broaddus, HT Lynch, L Chen, MS Daniels, P Conrad, MF Munsell, ...
Cancer 106 (1), 87-94, 2006
|CpG island methylation in aberrant crypt foci of the colorectum|
AOO Chan, RR Broaddus, PS Houlihan, JPJ Issa, SR Hamilton, A Rashid
The American journal of pathology 160 (5), 1823-1830, 2002
|Synchronous primary cancers of the endometrium and ovary: a single institution review of 84 cases|
PT Soliman, BM Slomovitz, RR Broaddus, CC Sun, JC Oh, PJ Eifel, ...
Gynecologic oncology 94 (2), 456-462, 2004
|Whole-exome sequencing combined with functional genomics reveals novel candidate driver cancer genes in endometrial cancer|
H Liang, LWT Cheung, J Li, Z Ju, S Yu, K Stemke-Hale, T Dogruluk, Y Lu, ...
Genome research 22 (11), 2120-2129, 2012
|A phase 2 study of the oral mammalian target of rapamycin inhibitor, everolimus, in patients with recurrent endometrial carcinoma|
BM Slomovitz, KH Lu, T Johnston, RL Coleman, M Munsell, RR Broaddus, ...
Cancer 116 (23), 5415-5419, 2010